$523.20
0.02% yesterday
NYSE, Apr 02, 10:00 pm CET
ISIN
US91324P1021
Symbol
UNH

UnitedHealth Target price 2025 - Analyst rating & recommendation

UnitedHealth Classifications & Recommendation:

Buy
97%
Sell
3%

UnitedHealth Price Target

Target Price $631.48
Price $523.20
Potential 20.70%
Number of Estimates 25
25 Analysts have issued a price target UnitedHealth 2026 . The average UnitedHealth target price is $631.48. This is 20.70% higher than the current stock price. The highest price target is $700.00 33.79% , the lowest is $590.00 12.77% .
A rating was issued by 31 analysts: 30 Analysts recommend UnitedHealth to buy, 0 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the UnitedHealth stock has an average upside potential 2026 of 20.70% . Most analysts recommend the UnitedHealth stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Dec '24 2025
Estimates
Revenue Billion $ 400.28 452.40
8.83% 13.02%
Net Margin 3.55% 5.72%
40.27% 61.33%

23 Analysts have issued a sales forecast UnitedHealth 2025 . The average UnitedHealth sales estimate is $452b . This is 13.02% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $457b 14.28% , the lowest is $442b 10.39% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $400b 8.83%
2025 $452b 13.02%
2026 $488b 7.79%
2027 $523b 7.33%
2028 $590b 12.69%

16 UnitedHealth Analysts have issued a net profit forecast 2025. The average UnitedHealth net profit estimate is $25.9b . This is 82.05% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $27.3b 91.76% , the lowest is $24.2b 69.88% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $14.2b 35.00%
2025 $25.9b 82.40%
2026 $29.5b 14.08%
2027 $33.7b 14.26%
2028 $37.6b 11.48%

Net Margin

2024 3.55% 40.27%
2025 5.72% 61.33%
2026 6.06% 5.94%
2027 6.45% 6.44%
2028 6.38% 1.09%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028


Dec '24 2025
Estimates
Earnings Per Share $ 15.51 28.29
35.00% 82.40%
P/E 18.49
EV/Sales 1.20

16 Analysts have issued a UnitedHealth forecast for earnings per share. The average UnitedHealth EPS is $28.29 . This is 82.05% higher than earnings per share in the financial year 2024. The highest EPS forecast is $29.80 91.76% , the lowest is $26.40 69.88% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $15.51 35.00%
2025 $28.29 82.40%
2026 $32.27 14.07%
2027 $36.88 14.29%
2028 $41.11 11.47%

P/E ratio

Current 33.67 62.34%
2025 18.49 45.08%
2026 16.21 12.33%
2027 14.19 12.46%
2028 12.73 10.29%

Based on analysts' sales estimates for 2025, the UnitedHealth stock is valued at an EV/Sales of 1.20 and an P/S ratio of 1.06 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.36 0.73%
2025 1.20 11.42%
2026 1.12 7.23%
2027 1.04 6.83%
2028 0.92 11.26%

P/S ratio

Current 1.20 2.58%
2025 1.06 11.52%
2026 0.98 7.23%
2027 0.91 6.83%
2028 0.81 11.25%

Current UnitedHealth Upgrades & Downgrades

Analyst Rating Action Date
Wells Fargo
Overweight
Overweight
Unchanged Jan 28 2025
Barclays
Overweight
Overweight
Unchanged Jan 17 2025
Keybanc
Overweight
Overweight
Unchanged Jan 17 2025
Cantor Fitzgerald
Overweight
Overweight
Unchanged Jan 17 2025
Truist Securities
Buy
Buy
Unchanged Jan 06 2025
Piper Sandler
Overweight
Overweight
Unchanged Jan 02 2025
Oppenheimer
Outperform
Outperform
Unchanged Dec 06 2024
Analyst Rating Date
Unchanged
Wells Fargo:
Overweight
Overweight
Jan 28 2025
Unchanged
Barclays:
Overweight
Overweight
Jan 17 2025
Unchanged
Keybanc:
Overweight
Overweight
Jan 17 2025
Unchanged
Cantor Fitzgerald:
Overweight
Overweight
Jan 17 2025
Unchanged
Truist Securities:
Buy
Buy
Jan 06 2025
Unchanged
Piper Sandler:
Overweight
Overweight
Jan 02 2025
Unchanged
Oppenheimer:
Outperform
Outperform
Dec 06 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today